Daniel Halberg

Daniel Halberg serves as the Vice-President of Medical Affairs at Sebela Pharmaceuticals Inc. since May 2022. Prior to this role, Daniel was the Director of Medical Scientific Affairs at Ironwood Pharmaceuticals for one year, and held the position of Head of Medical Affairs at Everlywell for a brief period. Daniel's extensive experience at Ironwood Pharmaceuticals also includes serving as Executive Medical Science Liaison from July 2012 to January 2021. Earlier in the career, Daniel was an Associate Professor at Samford University and held various roles at AstraZeneca LP, ultimately becoming Regional Director of Scientific Affairs. Daniel's academic involvement includes positions as Adjunct Associate Professor at the University of Louisiana at Monroe, as well as Assistant Professor at the University of Arkansas for Medical Sciences. Daniel holds a Ph.D. in Pharmacy Administration and Pharmacy Policy and Regulatory Affairs from the University of Florida and a BSBA in Finance from the same institution, along with an AA in Business and a marketing diploma from previous educational pursuits.